integrins has also been reported recently (Smith et al, 1996; Denda et al, 1998; Bayless et al, 1998) , as well as with a non-integrin cell surface receptor, CD-44 (Weber et al, 1996; Katagiri et al, 1999) . In vivo, OPN expression is increased in a variety of pathologies (reviewed in Rittling and Denhardt, 1999) , where it may act as a macrophage chemoattractant (Singh et al, 1990; Giachelli et al, 1998) , or as a repressor of induced nitric oxide synthase (iNOS) levels (Hwang et al, 1994; Rollo et al, 1996) : this activity may be especially relevant in pathologies involving ischaemia, in which nitric oxide (NO) production is thought to be an important mediator of tissue damage (Goligorsky et al, 1997; Noiri et al, 1999) . In vitro, the protein has cell attachment activity (Somerman et al, 1987; Chambers et al, 1993; Senger et al, 1994) , and stimulates migration of several cell types, including endothelial cells (Senger et al, 1996) and smooth muscle cells (Liaw et al, 1995) .
There is extensive evidence derived from observations made both in vitro and in vivo linking elevated osteopontin expression and transformation/tumorigenesis. The protein was originally characterized as transformation-associated due to its increased expression in transformed cell lines (Senger et al, 1983 ): indeed, a wide variety of transformed cells in culture express much higher levels of the protein than their normal counterparts (Senger et al, 1988) . These observations have been extended in that among transformed cells, the highest levels of expression were found in the most metastatic cell lines (Chambers et al, 1992a) . OPN is particularly highly expressed in ras-transformed cells , and ras has a direct effect on OPN transcription, via a ras-stimulated transcription factor that enhances transcription of the OPN gene (Guo et al, 1995) . OPN is also highly expressed in tumors in vivo. In papillomas and carcinomas induced by DMBA/TPA initiation/promotion in mouse skin, OPN expression levels correlate with tumor stage (Craig et al, 1990) . In mammary tumors arising in transgenic mice expressing ras and/or myc specifically in mammary gland, OPN expression is dramatically increased at both the message and protein level over levels in the corresponding normal mammary gland (Rittling and Novick, 1997) . OPN is typically overexpressed in human tumors (Brown et al, 1994; Bellahcène and Castronovo, 1995; Hirota et al, 1995; Tuck et al, 1998) , although the source of the protein in these malignancies can be either tumor cells or tumor-associated macrophages (Brown et al, 1994; Casson et al, 1997) A series of functional studies links OPN causally to tumorigenesis. Experiments in which OPN mRNA level was reduced in Osteopontin is required for full expression of the transformed phenotype by the ras oncogene already transformed cells indicated that the protein is important in transformation. Thus, transfection of different antisense OPN constructs or ribozymes into transformed, tumorigenic cells resulted in impaired anchorage-independent growth, as well as tumor-forming ability in vivo Su et al, 1995; Feng et al, 1995; Behrend et al, 1994) . Even more compelling are results showing that transfection of OPN expression constructs into cells producing benign tumors converts them to a malignant phenotype (Oates et al, 1996; Chen et al, 1997) .
In order to more clearly define the role OPN plays in transformation in vitro and tumorigenesis in vivo, we have examined these processes in cells derived from mice with a targeted disruption of the OPN gene . The results presented here indicate that while anchorage-independent growth and tumor formation can occur in the absence of OPN, these phenotypes, in particular tumor formation in vivo, are substantially enhanced in wildtype, OPN-expressing cells as compared to OPN deficient ones. Thus, OPN is required for full expression of the transformed phenotype.
MATERIALS AND METHODS

Preparation and immortalization of mouse embryo fibroblasts
Mouse embryo fibroblast (MEF) cells were prepared as described (Rittling, 1996) . Briefly, mouse embryos were removed from the uterus of 12-16-day pregnant mice, minced finely with scissors and digested with 0.125% trypsin. The cells obtained were plated on 150 mm tissue culture dishes at a density of 1 × 10 7 in DMEM (Gibco, Grand Island NY, USA) supplemented with 10% FBS (Gemini Bio-Products, Calabasas, CA, USA). For the first and second passages, cells were plated on 100 mm tissue culture dishes at a density of 1 × 10 6 ; in later passages, cells were plated at 3T3 density (8 × 10 5 ) on 100 mm dishes. For immortalization, cells were passed every three days and plated at 8 × 10 5 on 100 mm dishes (Rittling, 1996) . The numbers of cells plated (No), and the numbers of cells after three days of growth (N) were recorded, and the ratio (N/No) was calculated as a growth-rate indicator. Cells were considered to be immortalized when the ratio N/No became higher than 3.0.
Mice
Wildtype and OPN-deficient mice were housed and bred separately under specific pathogen-free conditions as described . Embryos were obtained from homozygous females, either wildtype or OPN-deficient, that had been mated to males of the same genotype. Mice used for embryo collection were in the 129 × C57BL/6 F2 genetic background.
Tetracycline-inducible cell lines
OPN-deficient 3T3 cells were transfected sequentially with pTetOff (pUHD-15-1) (Gossen and Bujard, 1992) , and with OPN under the control of the Tet operator, and the clones expressing the highest level of OPN selected for further analysis. The resulting clonal lines were transfected with pSV-Ha-ras, and foci were picked. Transformed cells from these foci were plated in soft agar at 10 5 cells per 35 mm well, in the presence or absence of 2 µg ml -1 tetracycline.
Transfection and selection
Plasmid DNA (pSV-Ha-ras: 20 µg per 100 mm dish, 10 µg per 60 mm dish) was introduced into cells by the calcium phosphate precipitation method, followed by glycerol shock (Malyankar et al, 1994) . Foci, identified as clumps of piled-up cells against a background monolayer, were picked after incubation for 2 weeks with medium containing 3% or 1% FBS, to select for cells with reduced growth factor requirements. Transfection efficiency was assessed by cotransfection with a β-galactosidase expression construct.
Growth curves
Cells were plated in 12-well dishes at 2.7 × 10 4 cells per well. Each day for 6 days, cells were removed from triplicate wells and counted, and the results plotted. Cell number at 3 days after plating, towards the end of the exponential growth phase, is reported.
Northern and western blotting
RNA preparation, analysis, and probes were as described (Rittling and Novick, 1997) . Western blotting for OPN was as in (Rittling et al, 1998b) and (Rittling and Feng, 1998) , using antiserum 732, developed in the OPN-deficient mice against mouse osteopontin (Kowalski et al, unpublished) . For quantification of ras protein levels, cells were scraped into RIPA buffer with protein inhibitors, and the protein concentration determined. Equal amounts of protein (25-35 µg) were separated on 12% SDS-PAGE and blotted. The blots were reacted with anti-H-ras antibody F235 (Santa Cruz Biotechnology, non-cross reactive with N-ras and K-ras) at 1 µg ml -1 .
Colony formation in soft agar
Anchorage-independent growth assays were performed using 6-well plates (Freedman and Shin, 1974) . Experiments were done in triplicate. Each well was coated with 2 ml of a base layer containing 0.6% agar, 1 × DMEM, 10% FBS. Subconfluent cells were collected in 10 ml of medium, counted and suspended in DMEM containing 10% FBS, 0.3% agar and 1 ml of the mixture containing 10 4 cells was plated over the 2 ml base layer in each well (three wells total for each cell line). After 14 days incubation with twice-a-week feeding (1 ml each time per dish of DMEM, 0.3% agar and 10% FBS), colonies (consisting of about 20 cells or more) in 10 high-power fields per dish were counted, and total colonies per dish calculated.
Tumor formation
Subconfluent, rapidly growing cells were collected and suspended in PBS at 1 × 10 6 cells per ml, and 0.5 ml of this cell suspension was injected subcutaneously in the upper dorsal region of 3-4 syngeneic (129 × C57Bl/6 F1, wildtype) and/or nude mice. Tumor size was measured with calipers every second day until the tumors reached 20% of the weight of the animal. Tumor volume was calculated according to the following formula: 4/3π (l-1) (w-1) 2 , the volume of an oblate ellipse, where l is the long dimension of the tumor, and w is the width, or short dimension, in mm; 1 mm was subtracted from each measurement to compensate for the thickness of the skin. In cases where results from only two mice are shown, a third animal in the experiment was sacrificed prior to 20 days, usually because the tumor had grown beyond 20% of the weight of the animal. For metastasis, 10 5 cells in 0.1 ml of PBS were injected via the lateral tail vein of syngeneic F 1 mice, and the mice were sacrificed after 4 weeks. Lungs were excised, fixed and cut into 1-2 mm slices prior to embedding. Several lung slices were embedded in a single block, and tumor size in the resultant H+E stained sections determined by measurement of the projected image. Mice were housed in microisolator cages in an AALACapproved animal facility, and all procedures were approved by the Rutgers University Institutional Review Board -Animal Care and Facilities Committee.
RESULTS
Establishment of immortal and transformed cell lines
Primary embryo fibroblasts were prepared from 13-15-day pregnant females. Initial experiments in which these primary cells were transfected with a mutant ras construct together with an activated p53 construct indicated that in both wildtype and OPN-deficient mice, the rate of focus formation was too low to be useful. Therefore, spontaneously immortalized cell lines were derived by continuous passage according to the 3T3 protocol. Three independent mouse embryo fibroblast (MEF) cultures from both wildtype and OPN-deficient mice were obtained, and passed to obtain immortal cell lines. While there is considerable variability in the rate at which different cell lines pass through crisis (Rittling, 1996) , there was no consistent difference between the wildtype and OPN-deficient cells (Figure 1) , nor was there any consistent difference in the average growth rate of the wildtype and OPNdeficient cell lines (data not shown). Previous work has shown that cells per 100 mm dish, and transfected with an activated ras expression construct. Two weeks following transfection, plates were fixed and stained, and the total foci in one representative 100 mm dish were counted. Transfection efficiency did not vary significantly between the transfections. Results from three independent experiments with six different 3T3 lines are shown.
Experiment Number of foci Number of foci (+/+) (-/-)
such spontaneously derived immortal cell lines represent fairly homogeneous populations (Rittling, 1996) . These immortal cell lines were transfected with an activated ras construct (pSV-Ha-ras), and grown in the presence of 3%, or in some cases 1%, fetal bovine serum for 2 weeks, to select for cells with reduced serum requirements. Morphologically transformed foci formed in every case with similar efficiencies (Figure 2 , Table  1 ), and there was no apparent effect of a lack of OPN on focus formation. The average number of foci formed was 85 ± 26.5 for WT cell lines and 87 ± 27.2 for OPN -/-lines.
For each immortal cell line, 10-20 foci were picked, and expanded. RNA was prepared from the resulting transformed cell lines while they were in exponential growth 3 days after plating, and analyzed for ras mRNA levels by northern blotting. This screening process was undertaken to select for transformed clones that expressed comparable levels of ras mRNA, to minimize differences between clones due to differential expression of the transfected ras allele. Thus, in each set of screened clones, wildtype and OPN-deficient clones that expressed similar levels of ras mRNA were selected and expanded for further analysis. From six independent immortal cell lines (three of each genotype) a total of 19 wildtype and 17 OPN-deficient ras-transformed cell lines were selected for further analysis.
OPN protein levels in the primary, immortal, and transformed cells were monitored by western blotting of media conditioned by the different cells. While the primary wildtype cells secrete readily detectable OPN, the level is increased about 10-fold in the corresponding immortal cells, and increased still further, another sevenfold, after ras transfection (Figure 3) . No OPN was detected in media conditioned by OPN-deficient cells. While the increase in OPN secretion after ras transformation was expected, and confirms that ras is active in these transformed cells, these results indicate that immortalization can also increase the amount of OPN secreted by cells.
Analysis of transformation in vitro
Following selection and expansion of the ras transformed cell lines, ras, cathepsin L, and OPN mRNA levels were analysed and normalized to β-actin mRNA levels. Cathepsin L expression has been shown in some cases to be, like OPN, induced by activated ras (Chambers et al, 1992b) , and so the level of this mRNA was used as a means of assessing ras activity in the individual cell lines. Figure 4 illustrates these data for a single set of cell lines: two additional sets were similarly analysed. Following normalization to β-actin mRNA levels, neither ras nor cathepsin L mRNA levels were found to differ significantly between the wildtype and OPN-deficient clones.
The ability of the transformed cell lines to grow under anchorage-independent conditions was tested by seeding 10 4 cells in 35 mm wells in 0.3% agar in complete medium with 10% FCS. After 2 weeks, colonies containing more than 20 cells were counted. The OPN-deficient cells were able to form colonies in soft agar under these conditions, and in several cell lines colonies were formed with as high efficiency as the wildtype cell lines (Figure 4) , and the morphology of the colonies was similar (data not shown). However, when the number of colonies formed per 10 4 cells plated was averaged over all the cell lines analyzed (19 wildtype and 17 OPN -/-), the wildtype cell lines were found to form nearly twice as many colonies as the OPN-deficient cells (Figure 5 ), despite considerable variability in the numbers of colonies formed by the individual cell lines. To confirm this observation, ras transformed OPN -/-cell lines were developed that expressed OPN under the control of a tetracycline-repressible promoter (Gossen and Bujard, 1992) . In these cells OPN expression is reduced about 10-fold in the presence of tetracycline. Growth of these cells in soft agar, but not on plastic, was reduced in the presence of tetracycline by about 20-30% (Figure 5 ), confirming that OPN under certain circumstances can facilitate anchorage-independent growth of cells.
Analysis of tumorigenesis in vivo
The ability of transformed cells to form colonies in soft agar is the parameter that most closely correlates with tumor forming ability in vivo (Freedman and Shin, 1974) . Accordingly, the ability of several of the wildtype and OPN-deficient cell lines to form tumors after injection subcutaneously into mice was assessed. Four sets of cell lines (wildtype and OPN-deficient) were selected Cell lines with comparable ras levels were selected from the initial screen and expanded. RNA was prepared after 3 days' growth, and growth in soft agar was determined as described in Methods. Lanes labelled PAP2 are RNA isolated from the metastatic, ras transformed NIH 3T3 cell line PAP2 . that could form colonies efficiently in soft agar and that had similar ras mRNA and protein levels ( Figure 6 , Table 2 ). These cells were collected, resuspended in PBS and injected subcutaneously into nude or syngeneic mice. The mice used for these injections were wildtype as there are at present no syngeneic OPN-deficient hosts for these 129 × C57Bl/6 F2 cells. Every second day after the tumors became palpable, the tumor size was measured with calipers. In every case the wildtype cells formed tumors significantly earlier than did the OPN-deficient cell lines (Figure 7 ) despite comparable growth of the cells in vitro both on plastic and in soft agar (Table 2) . Similar results were obtained with both syngeneic and nude mice ( Table 2 ). The main defect observed in the OPN -/-cells was in the lag-time before tumor formation could be detected: once the tumors were formed, the growth rate of the OPN -/-and wildtype tumors was similar (Figure 7 ). Thus OPN is required for efficient initiation of tumor growth in vivo in this system.
One pair of these cell lines was tested for the ability to form metastases in lungs following intravenous injection into syngeneic mice. The OPN-deficient cells were found to form fewer metastases, (5.5 ± 1.8 metastases per lung section for wt vs 1.2 ± 1.0 for OPN -/-cells; n = 3, P < 0.05), and those metastases were much smaller than those formed by WT cells (the mean cross-sectional area of the largest metastatic tumor examined in each section was 0.79 ± 0.42 mm 2 for wt and 0.162 ± 0.16 mm 2 for OPN -/-(n = 9; P < 0.01)). Table 2 . Table 2 Growth characteristics and tumour formation of different cell lines with high efficiency of growth in soft agar. The indicated cell lines were injected subcutaneously into mice. At the same passage, the growth rate of the cells on plastic and in soft agar was measured. 
Growth on
DISCUSSION
The development of mice deficient for osteopontin expression Liaw et al, 1998) has provided a unique system in which to compare directly the transformed properties of otherwise very similar cells in the presence and absence of osteopontin expression. The work presented here is important in that it provides an uncomplicated analysis of the role of OPN in multiple aspects of cellular transformation. Our results confirm and extend the long-held idea that OPN is important in the transformation process, in that the transformed phenotype was attenuated in the absence of OPN. Thus we observed lower rates on average of colony formation in soft agar, and dramatically reduced rates of primary tumor and metastasis growth in syngeneic and nude mice. The only aspect of transformation for which we did not detect a reduction in the OPN-deficient cells was in the process of focus formation: both the wildtype and osteopontin-deficient cells formed foci efficiently after ras transformation. This phenotype, focus formation, most likely represents a loss of contact inhibition of growth resulting from the expression of oncogenic ras, and we conclude that OPN, and by deduction also the integrins to which OPN binds in these cells, do not play a major role in this process. We also did not detect an effect of osteopontin on the process of spontaneous immortalization. This process requires an alteration in the cells, probably a mutation (Rittling, 1996) that enables the cells to overcome the growth restraints of senescence.
Our results indicate that the effects of OPN expression on anchorage-independent growth are complex. While antisense experiments suggested that OPN was necessary for the formation of colonies in soft agar (Su et al, 1995; Gardner et al, 1994) , we clearly show here that OPN-deficient cell lines can form colonies efficiently in soft agar, indicating that OPN is not absolutely required for this process in ras-transformed cells. However, our data show that OPN can enhance anchorage-independent growth. Thus, OPN is not strictly required for anchorage-independent growth, but can enhance such growth in some cell lines. Anchorage-independent growth in ras-transformed cells probably results from stimulation by activated ras of signaling pathways that mediate both growth factor and integrin-initiated signals (reviewed in Schwartz, 1997) . For example, MAPK activation by growth factors in normal cells requires adhesion through integrins (Renshaw et al, 1997) , while oncogenic ras stimulates MAPK independently of both growth factor and integrin ligation to allow anchorage-independent growth. The binding of soluble OPN to integrins such as the α v β 3 may stimulate the signal throughput of these pathways, even in the presence of activated ras, thereby enhancing anchorage-independent growth, much as transformed cells that are growth factor independent show higher rates of growth in the presence of growth factors.
The most pronounced effect of a lack of OPN that we observed was in the ability of the OPN-deficient transformed cells to form tumors. For these experiments, a subset of ras-transformed cell lines was selected that had similar ras levels and formed colonies efficiently in soft agar. While the OPN-deficient clones were able to form tumors in syngeneic or nude mice, they did so at a substantially slower rate than the wildtype cells. Thus, OPN clearly can enhance tumor formation in vivo. It is important to note here that the recipients for these tumor cell injections were wildtype mice, so OPN could have been produced by the stromal cells in the vicinity of the injection of the OPN-deficient cells. Thus hostderived OPN may have contributed to the ultimate ability of the OPN-deficient cells to form tumors. Indeed, we have found (Wu, Feng and Rittling, manuscript in preparation) that tumors arising from the OPN-deficient cells contain measurable amounts of OPN, which may have been supplied by infiltrating macrophages (Brown et al, 1994; Casson et al, 1997) or other sources.
We have considered several hypotheses to explain the mechanism of OPN's ability to enhance tumor formation. It is unlikely that OPN is acting in an autocrine manner to stimulate growth of the tumor cells themselves since these cells already show efficient anchorage-independent growth. Alternatively, high level OPN expression could protect cells from apoptosis in the first few days following tumor cell injection. A role for the OPN-binding integrins α 5 β 1 and α v β 3 in preventing apoptosis (or anoikis (Frisch and Ruoslahti, 1997) ) of transformed cells has previously been demonstrated (Montgomery et al, 1994; Zhang et al, 1995) . Denhardt and Chambers (1994) have proposed that OPN, by virtue of its ability to inhibit iNOS activity, protects tumor cells from attack by cytotoxic cell in vivo, and this may be a possible mechanism of action of OPN in stimulating tumor growth. The possible conflicting role of macrophages in OPN-dependent tumorigenesis has been discussed recently (Crawford et al, 1998) . Finally, OPN has been shown to stimulate migration of endothelial cells (Liaw et al, 1995) , particularly in association with VEGF (Senger et al, 1996) . Possibly, expression of OPN in the injected cells is required for optimal angiogenesis. This idea is supported by the observations that ligation of the α v β 3 integrin protects endothelial cells against apoptosis (Brooks et al, 1994a; Strömblad et al, 1996) and stimulates angiogenesis (Brooks et al, 1994b) , and that surface-bound OPN can protect endothelial cells from apoptosis (Scatena et al, 1998) . Work is in progress to distinguish these possibilities.
Experiments with transformed cells are hampered by the wellknown heterogeneity of such cells, making it difficult to make direct comparisons between different transformed cell lines. Our analysis of a large number of cell lines has allowed us to develop a consensus of the effects of OPN in vitro, despite considerable variability among individual cell lines. The results with tumor formation, however, were less variable, in that every cell line tested showed a slower rate of tumor growth. Thus, it may be that the effects of OPN are more pronounced in the whole animal than in culture, possibly reflecting an important role for this protein in mediating cellular interactions.
